Evidence map›Paper›PMID 39821393›Full record

ArticleJAMA network open2025

Neural Variability and Cognitive Control in Individuals With Opioid Use Disorder.

Jean Ye, Saloni Mehta, Hannah Peterson, Ahmad Ibrahim, Gul Saeed, Sarah Linsky, Iouri Kreinin, Sui Tsang, Uzoji Nwanaji-Enwerem, Anthony Raso and 11 more

Abstract read
In one paragraph

Article in JAMA network open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Jean YeInterdepartmental Neuroscience Program, Yale University, New Haven, Connecticut.
Saloni MehtaDepartment of Radiology & Biomedical Imaging, Yale School of Medicine, New Haven, Connecticut.
Hannah PetersonDepartment of Health Policy, Vanderbilt University, Nashville, Tennessee.
Ahmad IbrahimDepartment of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
Gul SaeedDepartment of Internal Medicine, Roger Williams Medical Center, Providence, Rhode Island.
Sarah LinskyYale School of Nursing, New Haven, Connecticut.
Iouri KreininPulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, Connecticut.
Sui TsangProgram of Aging, Yale University, New Haven, Connecticut.
Uzoji Nwanaji-EnweremYale School of Nursing, New Haven, Connecticut.
Anthony RasoFrank H. Netter MD School of Medicine, Quinnipiac University, Hamden, Connecticut.
Jagriti AroraDepartment of Radiology & Biomedical Imaging, Yale School of Medicine, New Haven, Connecticut.
Fuyuze TokogluDepartment of Radiology & Biomedical Imaging, Yale School of Medicine, New Haven, Connecticut.
Sarah W YipInterdepartmental Neuroscience Program, Yale University, New Haven, Connecticut.
C Alice HahnYale Center for Clinical Investigation, Yale School of Medicine, New Haven, Connecticut.
Cheryl LacadieDepartment of Radiology & Biomedical Imaging, Yale School of Medicine, New Haven, Connecticut.
Abigail S GreeneDepartment of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts.
R Todd ConstableInterdepartmental Neuroscience Program, Yale University, New Haven, Connecticut.
Declan T BarryDepartment of Psychiatry, Yale School of Medicine, New Haven, Connecticut.
Nancy S RedekerSchool of Nursing, University of Connecticut, Storrs.
H Klar YaggiDepartment of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
Dustin ScheinostInterdepartmental Neuroscience Program, Yale University, New Haven, Connecticut.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
The Collaboration Linking Opioid Use Disorder and Sleep ("CLOUDS") StudyU01HL150596 · NHLBI · YALE UNIVERSITY · PI BARRY, DECLAN T., REDEKER, NANCY S · 2019 to 2024
$5.1M
An Individualized, Multidimensional Dimensional Approach to PsychopathologyR01MH121095 · NIMH · YALE UNIVERSITY · PI CONSTABLE, R TODD, SCHEINOST, DUSTIN · 2019 to 2023
$4.2M
NCATS NIH HHS UL1 TR001863NHLBI NIH HHS U01 HL150596NIMH NIH HHS R01 MH121095
6 · The paper itself

Abstract

Importance: Opioid use disorder (OUD) impacts millions of people worldwide. Prior studies investigating its underpinning neural mechanisms have not often considered how brain signals evolve over time, so it remains unclear whether brain dynamics are altered in OUD and have subsequent behavioral implications. Objective: To characterize brain dynamic alterations and their association with cognitive control in individuals with OUD. Design, Setting, and Participants: This case-control study collected functional magnetic resonance imaging (fMRI) data from individuals with OUD and healthy control (HC) participants. The study was performed at an academic research center and an outpatient clinic from August 2019 to May 2024. Exposure: Individuals with OUD were all recently stabilized on medications for OUD (<24 weeks). Main Outcomes and Measures: Recurring brain states supporting different cognitive processes were first identified in an independent sample with 390 participants. A multivariate computational framework extended these brain states to the current dataset to assess their moment-to-moment engagement within each individual. Resting-state and naturalistic fMRI investigated whether brain dynamic alterations were consistently observed in OUD. Using a drug cue paradigm in participants with OUD, the association between cognitive control and brain dynamics during exposure to opioid-related information was studied. Variations in continuous brain state engagement (ie, state engagement variability [SEV]) were extracted during resting-state, naturalistic, and drug-cue paradigms. Stroop assessed cognitive control. Results: Overall, 99 HC participants (54 [54.5%] female; mean [SD] age, 31.71 [12.16] years) and 76 individuals with OUD (31 [40.8%] female; mean [SD] age, 39.37 [10.47] years) were included. Compared with HC participants, individuals with OUD demonstrated consistent SEV alterations during resting-state (99 HC participants; 71 individuals with OUD; F4,161 = 6.83; P < .001) and naturalistic (96 HC participants; 76 individuals with OUD; F4,163 = 9.93; P < .001) fMRI. Decreased cognitive control was associated with lower SEV during the rest period of a drug cue paradigm among 70 participants with OUD. For example, lower incongruent accuracy scores were associated with decreased transition SEV (ρ58 = 0.34; P = .008). Conclusions and Relevance: In this case-control study of brain dynamics in OUD, individuals with OUD experienced greater difficulty in effectively engaging various brain states to meet changing demands. Decreased cognitive control during the rest period of a drug cue paradigm suggests that these individuals had an impaired ability to disengage from opioid-related information. The current study introduces novel information that may serve as groundwork to strengthen cognitive control and reduce opioid-related preoccupation in OUD.

Indexed as

BrainCognitionOpioid-Related DisordersAdultCase-Control StudiesFemaleHumansMagnetic Resonance ImagingMaleMiddle Aged

Identifiers

PMID39821393
PMCPMC11742521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.